A systematic cochrane review of corrector therapies (with or without potentiators) for people with cystic fibrosis with class II gene variants (most commonly F508DEL).
作者信息
Southern K W, Murphy J, Sinha I P, Nevitt S J
机构信息
Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
Department of Health Data Science, University of Liverpool, Liverpool, UK.
出版信息
Paediatr Respir Rev. 2021 Jun;38:33-36. doi: 10.1016/j.prrv.2021.03.001. Epub 2021 Mar 11.
PMID:33875358
Abstract
摘要
Zotero 插件